ROS‐Responsive Nanobubbles for Dual‐Enhanced Ultrasound and Magnetic Resonance Imaging of Tumor Oxidative Stress
Advanced Science · 2026-08 · 13 (44)
DOI: 10.1002/advs.202600071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.05.2026. Verfasst von Wonsik Jung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, KAIST Institute for BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of K…. Hauptthemen laut MEDLINE: Oxidative Stress, Reactive Oxygen Species, Magnetic Resonance Imaging, Neoplasms. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Asan Institute for Life Sciences, Asan Medical Center, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Reactive oxygen species (ROS) are key biomarkers of oxidative stress in the tumor microenvironment (TME), yet their non‐invasive, real‐time visualization remains challenging. Here, we present biotinylated PEGylated bilirubin nanobubbles encapsulating perfluoropentane gas (bt‐PEG‐BR@PFP) as ROS‐responsive contrast agents for dual‐modality ultrasound (US) and magnetic resonance imaging (MRI). Upon ROS exposure, the bilirubin shell undergoes oxidative degradation, leading to nanobubble fusion and signal amplification in both US and T 2 *‐weighted MRI. In vitro, biotin‐mediated cellular uptake and ROS‐induced fusion were validated in A549 cancer cells. In vivo, intratumoral injection of bt‐PEG‐BR@PFP into dual‐tumor xenografts led to a >3.7‐fold increase in US signal intensity in ROS‐high A549 tumors compared to ROS‐low DU145 tumors, which was abolished by the ROS scavenger N‐acetylcysteine. Following systemic administration, the nanobubbles accumulated selectively in A549 tumors through biotin‐mediated targeting and produced ∼50‐fold higher US signal than in DU145 tumors. In contrast, the clinical agent SonoVue showed no such tumor selectivity and ROS‐responsive signal enhancement. MRI studies revealed a time‐dependent signal drop only in A549 tumors treated with bt‐PEG‐BR@PFP, consistent with ROS‐mediated nanobubble fusion. These results highlight bt‐PEG‐BR@PFP as a promising and clinically translatable platform for non‐invasive, dual‐modality imaging of tumor oxidative stress, with potential utility in various ROS‐associated pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, KAIST Institute for BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
- Center for Precision Bio-Nanomedicine, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
- Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
ORCID-Profile: Wonsik Jung, Youngju Son, Sung-Hong Park, Sangyong Jon
Förderung
- National Research Foundation of Korea
- Asan Institute for Life Sciences, Asan Medical Center
- Korea Health Industry Development Institute
Zitieren
APA
Jung, W., Son, Y., Lee, D. Y., Jeon, Y., Asaddudin, M., Park, S. H., & Jon, S. (2026). ROS‐Responsive Nanobubbles for Dual‐Enhanced Ultrasound and Magnetic Resonance Imaging of Tumor Oxidative Stress. Advanced Science, 13(44). https://doi.org/10.1002/advs.202600071
Vancouver
Jung W, Son Y, Lee DY, Jeon Y, Asaddudin M, Park SH, et al. ROS‐Responsive Nanobubbles for Dual‐Enhanced Ultrasound and Magnetic Resonance Imaging of Tumor Oxidative Stress. Advanced Science. 2026;13(44). doi:10.1002/advs.202600071
BibTeX
@article{Jung2026,
author = {Jung, Wonsik and Son, Youngju and Lee, Dong Yun and Jeon, Youngeun and Asaddudin, Muhammad and Park, Sung-Hong and Jon, Sangyong},
title = {ROS‐Responsive Nanobubbles for Dual‐Enhanced Ultrasound and Magnetic Resonance Imaging of Tumor Oxidative Stress},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {44},
doi = {10.1002/advs.202600071}
}
EUVIMED